Taking into account successive treatment lines in the analysis of a colorectal cancer randomised trial.
暂无分享,去创建一个
S Michiels | J. Pignon | M. Ducreux | S. Michiels | P. Rougier | O. Bouché | J Pénichoux | O Bouché | P-L Etienne | P Texereau | D Auby | P Rougier | M Ducreux | J-P Pignon | P. Etienne | P. Texereau | D. Auby | J. Pénichoux
[1] R J Glynn,et al. Counting recurrent events in cancer research. , 2001, Journal of the National Cancer Institute.
[2] Pierre Michel,et al. Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trial. , 2011, The Lancet. Oncology.
[3] W. Scheithauer,et al. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] Lisa Kuramoto,et al. On reporting results from randomized controlled trials with recurrent events , 2008, BMC medical research methodology.
[5] Virginie Rondeau,et al. frailtypack: A computer program for the analysis of correlated failure time data using penalized likelihood estimation , 2005, Comput. Methods Programs Biomed..
[6] C. Wilson,et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Luc Duchateau,et al. Evolution of recurrent asthma event rate over time in frailty models , 2003 .
[8] Richard J Stephens,et al. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial , 2007, The Lancet.
[9] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[10] C. Tournigand,et al. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Daniel J Sargent,et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] R. James,et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.
[13] Linda Mol,et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial , 2007, The Lancet.
[14] M. Ducreux,et al. Randomized strategical trial of chemotherapy in metastatic colorectal cancer (FFCD 2000–05): Preliminary results , 2007 .
[15] K. Khan,et al. Analysis of recurrent events: a systematic review of randomised controlled trials of interventions to prevent falls. , 2008, Age and Ageing.